vs

Side-by-side financial comparison of Castellum, Inc. (CTM) and 908 Devices Inc. (MASS). Click either name above to swap in a different company.

908 Devices Inc. is the larger business by last-quarter revenue ($17.4M vs $12.6M, roughly 1.4× Castellum, Inc.). 908 Devices Inc. runs the higher net margin — 24.0% vs -10.5%, a 34.5% gap on every dollar of revenue. On growth, Castellum, Inc. posted the faster year-over-year revenue change (21.9% vs 21.2%). Over the past eight quarters, 908 Devices Inc.'s revenue compounded faster (53.0% CAGR vs 5.3%).

Castellum, Inc. is a U.S.-based cybersecurity and information technology services provider. It caters to government defense agencies, public sector entities, and commercial enterprise clients, offering threat detection, data protection, cloud security, and managed IT solutions to help organizations mitigate cyber risks and safeguard critical digital infrastructure.

908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.

CTM vs MASS — Head-to-Head

Bigger by revenue
MASS
MASS
1.4× larger
MASS
$17.4M
$12.6M
CTM
Growing faster (revenue YoY)
CTM
CTM
+0.8% gap
CTM
21.9%
21.2%
MASS
Higher net margin
MASS
MASS
34.5% more per $
MASS
24.0%
-10.5%
CTM
Faster 2-yr revenue CAGR
MASS
MASS
Annualised
MASS
53.0%
5.3%
CTM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTM
CTM
MASS
MASS
Revenue
$12.6M
$17.4M
Net Profit
$-1.3M
$4.2M
Gross Margin
33.9%
52.7%
Operating Margin
-11.1%
17.8%
Net Margin
-10.5%
24.0%
Revenue YoY
21.9%
21.2%
Net Profit YoY
51.8%
121.5%
EPS (diluted)
$-0.02
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTM
CTM
MASS
MASS
Q4 25
$12.6M
$17.4M
Q3 25
$14.6M
$14.0M
Q2 25
$14.0M
$13.0M
Q1 25
$11.7M
$11.8M
Q4 24
$10.3M
$14.3M
Q3 24
$11.6M
$14.5M
Q2 24
$11.5M
$11.5M
Q1 24
$11.3M
$7.4M
Net Profit
CTM
CTM
MASS
MASS
Q4 25
$-1.3M
$4.2M
Q3 25
$415.4K
$-15.0M
Q2 25
$-322.1K
$-13.3M
Q1 25
$-1.2M
$43.6M
Q4 24
$-2.7M
$-19.4M
Q3 24
$-1.3M
$-29.3M
Q2 24
$-1.8M
$-12.5M
Q1 24
$-4.1M
$-10.9M
Gross Margin
CTM
CTM
MASS
MASS
Q4 25
33.9%
52.7%
Q3 25
37.6%
52.5%
Q2 25
36.1%
48.9%
Q1 25
39.0%
47.0%
Q4 24
40.0%
46.5%
Q3 24
42.7%
53.6%
Q2 24
40.6%
53.8%
Q1 24
39.8%
52.4%
Operating Margin
CTM
CTM
MASS
MASS
Q4 25
-11.1%
17.8%
Q3 25
3.0%
-116.6%
Q2 25
-2.7%
-116.3%
Q1 25
-12.7%
-93.6%
Q4 24
-15.7%
-116.8%
Q3 24
-11.9%
-168.7%
Q2 24
-13.6%
-74.5%
Q1 24
-23.6%
-102.5%
Net Margin
CTM
CTM
MASS
MASS
Q4 25
-10.5%
24.0%
Q3 25
2.8%
-107.0%
Q2 25
-2.3%
-102.1%
Q1 25
-10.0%
370.2%
Q4 24
-26.6%
-135.6%
Q3 24
-11.0%
-201.8%
Q2 24
-16.0%
-109.5%
Q1 24
-36.3%
-147.1%
EPS (diluted)
CTM
CTM
MASS
MASS
Q4 25
$-0.02
$0.09
Q3 25
$0.00
$-0.41
Q2 25
$0.00
$-0.37
Q1 25
$-0.01
$1.23
Q4 24
$-0.05
$-0.58
Q3 24
$-0.02
$-0.84
Q2 24
$-0.03
$-0.37
Q1 24
$-0.08
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTM
CTM
MASS
MASS
Cash + ST InvestmentsLiquidity on hand
$113.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.8M
$143.7M
Total Assets
$41.9M
$190.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTM
CTM
MASS
MASS
Q4 25
$113.0M
Q3 25
$112.1M
Q2 25
$118.6M
Q1 25
$124.3M
Q4 24
$69.6M
Q3 24
$71.7M
Q2 24
$77.4M
Q1 24
$134.2M
Total Debt
CTM
CTM
MASS
MASS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$8.0M
Q3 24
$8.3M
Q2 24
$8.7M
Q1 24
$9.0M
Stockholders' Equity
CTM
CTM
MASS
MASS
Q4 25
$35.8M
$143.7M
Q3 25
$36.7M
$136.3M
Q2 25
$31.8M
$148.8M
Q1 25
$26.1M
$159.4M
Q4 24
$20.2M
$114.6M
Q3 24
$12.0M
$131.0M
Q2 24
$12.1M
$156.4M
Q1 24
$12.8M
$156.9M
Total Assets
CTM
CTM
MASS
MASS
Q4 25
$41.9M
$190.1M
Q3 25
$46.3M
$190.9M
Q2 25
$43.4M
$191.7M
Q1 25
$41.1M
$196.0M
Q4 24
$37.8M
$159.5M
Q3 24
$28.8M
$178.3M
Q2 24
$29.5M
$208.8M
Q1 24
$30.5M
$189.8M
Debt / Equity
CTM
CTM
MASS
MASS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
0.69×
Q2 24
0.72×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTM
CTM
MASS
MASS
Operating Cash FlowLast quarter
$-661.7K
$1.3M
Free Cash FlowOCF − Capex
$1.3M
FCF MarginFCF / Revenue
7.6%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.32×
TTM Free Cash FlowTrailing 4 quarters
$-24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTM
CTM
MASS
MASS
Q4 25
$-661.7K
$1.3M
Q3 25
$1.0M
$-4.2M
Q2 25
$214.2K
$-5.8M
Q1 25
$-2.5M
$-15.0M
Q4 24
$-394.4K
$-2.2M
Q3 24
$742.2K
$-5.6M
Q2 24
$748.6K
$-13.0M
Q1 24
$23.7K
$-9.4M
Free Cash Flow
CTM
CTM
MASS
MASS
Q4 25
$1.3M
Q3 25
$957.0K
$-4.9M
Q2 25
$-5.9M
Q1 25
$-15.2M
Q4 24
$-2.4M
Q3 24
$738.9K
$-5.8M
Q2 24
$-13.7M
Q1 24
$-10.3M
FCF Margin
CTM
CTM
MASS
MASS
Q4 25
7.6%
Q3 25
6.5%
-34.9%
Q2 25
-45.3%
Q1 25
-128.9%
Q4 24
-17.0%
Q3 24
6.4%
-39.7%
Q2 24
-119.4%
Q1 24
-138.2%
Capex Intensity
CTM
CTM
MASS
MASS
Q4 25
0.0%
Q3 25
0.3%
4.9%
Q2 25
0.9%
Q1 25
1.4%
Q4 24
0.0%
1.3%
Q3 24
0.0%
1.1%
Q2 24
0.0%
5.6%
Q1 24
0.0%
12.2%
Cash Conversion
CTM
CTM
MASS
MASS
Q4 25
0.32×
Q3 25
2.41×
Q2 25
Q1 25
-0.34×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTM
CTM

Segment breakdown not available.

MASS
MASS

Products$14.3M82%
Services$3.0M18%

Related Comparisons